P50 gating deficit in Alzheimer dementia correlates to frontal neuropsychological function

Neurobiology of Aging

Volumn 31, Issue 3, 2010, Pages 416-424

  Thomas, Christine ^a,b   vom Berg, Ingo ^a   Rupp, Andre ^a   Seidl, Ulrich ^a   Schröder, Johannes ^a   Roesch Ely, Daniela ^a   Kreisel, Stefan H ^b   Mundt, Christoph ^a   Weisbrod, Matthias ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

^c SRH Klinikum   (Germany)

Author keywords

Aging; Alzheimer's disease; Auditory evoked potentials; Auditory sensory gating; Frontal inhibition

Indexed keywords

PIPAMPERONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DECLARATIVE MEMORY; DEPRESSION; EVENT RELATED POTENTIAL; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROGNOSIS; SLEEP DISORDER; WORKING MEMORY;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ATTENTION; AUDITORY PERCEPTION; BRAIN; COGNITION; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS;

EID: 74249084512     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.05.002     Document Type: Article

References (49)

1. Adler L.E., Hoffer L.D., Wiser A., and Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry 150 (1993) 1856-1861
2. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., and Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 24 (1998) 189-202
3. Amieva H., Phillips L.H., Della Sala S., and Henry J.D. Inhibitory functioning in Alzheimer's disease. Brain 127 (2004) 949-964
4. Baddeley A.D., Baddeley H.A., Bucks R.S., and Wilcock G.K. Attentional control in Alzheimer's disease. Brain 124 (2001) 1492-1508
5. Barth S., Schonknecht P., Pantel J., and Schroder J. Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery. Fortschr. Neurol. Psychiatr. 73 (2005) 568-576
6. Boutros N.N., and Belger A. Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating. Biol. Psychiatry 45 (1999) 917-922
7. Boutros N.N., Belger A., Campbell D., D'Souza C., and Krystal J. Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report. Psychiatry Res. 88 (1999) 119-130
8. Braak H., de Vos R.A., Jansen E.N., Bratzke H., and Braak E. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog. Brain Res. 117 (1998) 267-285
9. Braak H., Del Tredici K., Schultz C., and Braak E. Vulnerability of select neuronal types to Alzheimer's disease. Ann. NY Acad. Sci. 924 (2000) 53-61
10. Bramon E., Rabe-Hesketh S., Sham P., Murray R.M., and Frangou S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr. Res. 70 (2004) 315-329
11. Buchanan R.W., Summerfelt A., Tek C., and Gold J. An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia. Schizophr. Res. 59 (2003) 29-33
12. Buchwald J.S., Erwin R.J., Read S., Van Lancker D., and Cummings J.L. Midlatency auditory evoked responses: differential abnormality of P1 in Alzheimer's disease. Electroencephalogr. Clin. Neurophysiol. 74 (1989) 378-384
13. Cancelli I., Cadore I.P., Merlino G., Valentinis L., Moratti U., Bergonzi P., Gigli G.L., and Valente M. Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer's disease. J. Clin. Neurophysiol. 23 (2006) 421-425
14. Chao L.L., and Knight R.T. Prefrontal deficits in attention and inhibitory control with aging. Cereb. Cortex 7 (1997) 63-69
15. Clementz B.A., Geyer M.A., and Braff D.L. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr. Res. 30 (1998) 71-80
16. Court J., Martin-Ruiz C., Piggott M., Spurden D., Griffiths M., and Perry E. Nicotinic receptor abnormalities in Alzheimer's disease. Biol. Psychiatry 49 (2001) 175-184
17. Cullum C.M., Harris J.G., Waldo M.C., Smernoff E., Madison A., Nagamoto H.T., Griffith J., Adler L.E., and Freedman R. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr. Res. 10 (1993) 131-141
18. D'Andrea M.R., and Nagele R.G. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. Curr. Pharm. Des. 12 (2006) 677-684
19. Erickson K.I., Colcombe S.J., Wadhwa R., Bherer L., Peterson M.S., Scalf P.E., Kim J.S., Alvarado M., and Kramer A.F. Training-induced plasticity in older adults: effects of training on hemispheric asymmetry. Neurobiol. Aging 28 (2007) 272-283
20. Ermutlu M.N., Demiralp T., and Karamursel S. The effects of interstimulus interval on sensory gating and on preattentive auditory memory in the oddball paradigm. Can magnitude of the sensory gating affect preattentive auditory comparison process?. Neurosci. Lett. 412 (2007) 1-5
21. Erwin R.J., Turetsky B.I., Moberg P., Gur R.C., and Gur R.E. P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention. Schizophr. Res. 33 (1998) 157-167
22. Fein G., Biggins C., and van Dyke C. The auditory P50 response is normal in Alzheimer's disease when measured via a paired click paradigm. Electroencephalogr. Clin. Neurophysiol. 92 (1994) 536-545
23. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 3 (1975) 189-198
24. Freedman R., Olincy A., Ross R.G., Waldo M.C., Stevens K.E., Adler L.E., and Leonard S. The genetics of sensory gating deficits in schizophrenia. Curr. Psychiatry Rep. 5 (2003) 155-161
25. Golob E.J., Miranda G.G., Johnson J.K., and Starr A. Sensory cortical interactions in aging, mild cognitive impairment, and Alzheimer's disease. Neurobiol. Aging 22 (2001) 755-763
26. Golob E.J., Irimajiri R., and Starr A. Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia. Brain. 130 (2007) 740-752
27. Griffith J.M., O'Neill J.E., Petty F., Garver D., Young D., and Freedman R. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia. Biol. Psychiatry 44 (1998) 98-106
28. Irimajiri R., Golob E.J., and Starr A. Auditory brain-stem, middle- and long-latency evoked potentials in mild cognitive impairment. Clin. Neurophysiol. 116 (2005) 1918-1929
29. Jessen F., Kucharski C., Fries T., Papassotiropoulos A., Hoenig K., Maier W., and Heun R. Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease. Am. J. Psychiatry 158 (2001) 1319-1321
30. Kisley M.A., Davalos D.B., Engleman L.L., Guinther P.M., and Davis H.P. Age-related change in neural processing of time-dependent stimulus features. Brain Res. Cogn. Brain Res. 25 (2005) 913-925
31. Korzyukov O., Pflieger M.E., Wagner M., Bowyer S.M., Rosburg T., Sundaresan K., Elger C.E., and Boutros N.N. Generators of the intracranial P50 response in auditory sensory gating. Neuroimage 35 (2007) 814-826
32. Krause M., Hoffmann W.E., and Hajos M. Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats. Biol. Psychiatry 53 (2003) 244-253
33. Levin E.D., McClernon F.J., and Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl.) 184 (2006) 523-539
34. Lucas-Meunier E., Fossier P., Baux G., and Amar M. Cholinergic modulation of the cortical neuronal network. Pflugers Arch. 446 (2003) 17-29
35. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
36. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., and Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 9 (1989) 1159-1165
37. Namba H., Iyo M., Shinotoh H., Nagatsuka S., Fukushi K., and Irie T. Preserved acetylcholinesterase activity in aged cerebral cortex. Lancet 351 (1998) 881-882
38. Olincy A., Harris J.G., Johnson L.L., Pender V., Kongs S., Allensworth D., Ellis J., Zerbe G.O., Leonard S., Stevens K.E., Stevens J.O., Martin L., Adler L.E., Soti F., Kem W.R., and Freedman R. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch. Gen. Psychiatry 63 (2006) 630-638
39. Oswald W.D., and Fleischmann U.M. Nürnberger-Alters-Inventar (NAI) (1997), Huber, Bern
40. Pekkonen E., Jaaskelainen I.P., Kaakkola S., and Ahveninen J. Cholinergic modulation of preattentive auditory processing in aging. Neuroimage 27 (2005) 387-392
41. Perry R.J., and Hodges J.R. Attention and executive deficits in Alzheimer's disease. A critical review. Brain 122 Pt 3 (1999) 383-404
42. Potter D., Summerfelt A., Gold J., and Buchanan R.W. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophr. Bull. 32 (2006) 692-700
43. Raemaekers M., Vink M., van den Heuvel M.P., Kahn R.S., and Ramsey N.F. Effects of aging on BOLD fMRI during prosaccades and antisaccades. J. Cogn. Neurosci. 18 (2006) 594-603
44. Reitan R.M. Validity of the trailmaking test as an indication of organic brain damage. Percept. Mot. Skills 8 (1958) 271-276
45. Repovs G., and Baddeley A. The multi-component model of working memory: explorations in experimental cognitive psychology. Neuroscience 139 (2006) 5-21
46. Schonknecht P., Pantel J., Kruse A., and Schroder J. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects. Am. J. Psychiatry 162 (2005) 2071-2077
47. Soininen H.S., Karhu J., Partanen J., Paakkonen A., Jousmaki V., Hanninen T., Hallikainen M., Partanen K., Laakso M.P., Koivisto K., et al. Habituation of auditory N100 correlates with amygdaloid volumes and frontal functions in age-associated memory impairment. Physiol. Behav. 57 (1995) 927-935
48. Wechsler D. Wechsler Memory Scale-Revised (1987), The Psychological Corporation, San Antonio, TX
49. Weisser R., Weisbrod M., Roehrig M., Rupp A., Schroeder J., and Scherg M. Is frontal lobe involved in the generation of auditory evoked P50?. Neuroreport 12 (2001) 3303-3307